Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > 50 cents? A pittance for such valuable assets.

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Jan 13, 2016 7:33pm

143 Views

Post# 24456096

RE:50 cents? A pittance for such valuable assets.

Read my earlier note carefully - my discussion with Robert Wares. Try to read between the lines. Wexford forced their hand, for reasons unrelated to NioGold. If you believe in Marban, your patience will likely be rewarded through Oban's success, likely with lesser risk.

We don't need to complicate matters or speculate without any basis - things are moving along for very defined reasons...

-- MM

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages